JP2020093998A - Liquid oral composition - Google Patents

Liquid oral composition Download PDF

Info

Publication number
JP2020093998A
JP2020093998A JP2018232680A JP2018232680A JP2020093998A JP 2020093998 A JP2020093998 A JP 2020093998A JP 2018232680 A JP2018232680 A JP 2018232680A JP 2018232680 A JP2018232680 A JP 2018232680A JP 2020093998 A JP2020093998 A JP 2020093998A
Authority
JP
Japan
Prior art keywords
bitterness
liquid oral
oral composition
weight
tranexamic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018232680A
Other languages
Japanese (ja)
Other versions
JP7108304B2 (en
Inventor
真由美 高木
Mayumi Takagi
真由美 高木
真一 洲嵜
Shinichi Suzaki
真一 洲嵜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Menard Cosmetic Co Ltd
Original Assignee
Nippon Menard Cosmetic Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Menard Cosmetic Co Ltd filed Critical Nippon Menard Cosmetic Co Ltd
Priority to JP2018232680A priority Critical patent/JP7108304B2/en
Publication of JP2020093998A publication Critical patent/JP2020093998A/en
Application granted granted Critical
Publication of JP7108304B2 publication Critical patent/JP7108304B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)

Abstract

To provide a liquid oral composition that reduces bitterness and stimulus peculiar to cetylpyridinium chloride and tranexamic acid and prevents discoloration with time and has good appearance stability.SOLUTION: A liquid oral composition contains following components (A)-(C): (A) cetylpyridinium chloride 0.01-0.1 wt.%, (B) tranexamic acid 0.01-0.1 wt.%, and (C) Apocynum venetum extract 0.00005-0.01 wt.% and has a pH of 5.0-6.5.SELECTED DRAWING: None

Description

本願発明は、液体口腔用組成物に関し、さらに詳細には塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性を低減し、さらに、経時での変色が抑制され外観安定性に優れる液体口腔用組成物に関する。 The present invention relates to a liquid oral composition, more specifically, a liquid oral composition that reduces bitterness and irritation peculiar to cetylpyridinium chloride and tranexamic acid, and is excellent in appearance stability by suppressing discoloration over time. Regarding things.

従来、口腔用組成物には、歯周疾患の予防又は治療のために、殺菌剤や抗プラスミン剤等が配合されている。殺菌剤としては、例えば第四級アンモニウム塩型カチオン殺菌剤である塩化セチルピリジニウム等が知られている。しかし、塩化セチルピリジニウムには特有の苦味があり、また刺激性も有しているため、口腔に適用するためには、これらをできるだけ低減させることが求められる。 BACKGROUND ART Conventionally, a bactericidal agent, an antiplasmin agent, and the like have been incorporated into oral compositions for the prevention or treatment of periodontal diseases. Known bactericides include, for example, quaternary ammonium salt type cationic bactericides such as cetylpyridinium chloride. However, since cetylpyridinium chloride has a peculiar bitterness and also has an irritating property, in order to apply it to the oral cavity, it is required to reduce these as much as possible.

また、抗プラスミン剤としては、例えばトラネキサム酸等が知られている。しかし、トラネキサム酸にも特有の苦味があり、さらには経時的に外観が黄色に変色するという問題点もある。 In addition, tranexamic acid and the like are known as antiplasmin agents. However, tranexamic acid also has a peculiar bitterness, and there is also a problem that the appearance turns yellow with time.

塩化セチルピリジニウム由来の苦味の問題を解決するために、ステビア系甘味剤の併用によって苦味及び刺激を改善し、嗜好性を向上する技術が提案され(特許文献1)、香料成分によってマスキングする方法が提案されている(特許文献2)。しかし、これらの方法は、甘味剤の甘味によって製剤が甘くなりすぎてしまう場合や、香料自身の刺激によって使用感が悪くなってしまう場合がある。 In order to solve the problem of bitterness derived from cetylpyridinium chloride, a technique of improving bitterness and irritation by the combined use of a stevia sweetener and improving palatability has been proposed (Patent Document 1), and a method of masking with a flavor component is proposed. It has been proposed (Patent Document 2). However, in these methods, the preparation may become too sweet due to the sweetness of the sweetener, or the sensation of the fragrance itself may deteriorate the usability.

トラネキサム酸由来の苦味の問題を解決するために、酢酸l−メンチルを用いることによって、トリクロサンとの併用によるしつこい苦味を改善する技術が提案されている(特許文献3)。しかし、これらの方法は、酢酸l−メンチル自身に刺激感があるため、使用者の嗜好に合わない場合がある。 In order to solve the problem of bitterness derived from tranexamic acid, a technique has been proposed in which 1-menthyl acetate is used to improve persistent bitterness in combination with triclosan (Patent Document 3). However, these methods may not suit the taste of the user because l-menthyl acetate itself has a sensation.

さらに、塩化セチルピリジニウム及びトラネキサム酸にマルチトールを配合することで苦味をマスキングする技術が提案されている(特許文献4)が、これについても甘味を増やす事による苦味のマスキングであるため、製剤が甘くなりすぎて、使用感が悪くなってしまう場合がある。 Furthermore, a technique of masking bitterness by blending maltitol with cetylpyridinium chloride and tranexamic acid has been proposed (Patent Document 4), but this is also masking of bitterness by increasing sweetness, and therefore the formulation is It may become too sweet and the usability may deteriorate.

このように、塩化セチルピリジニウムとトラネキサム酸を併用しているにも関わらず、苦味及び刺激性が低減され、かつ使用感においても満足できるもので、しかも外観安定性に優れる口腔用組成物はいまだ達成できていない。従って、これらのすべてを満たした口腔用組成物の開発が望まれている。 Thus, despite the combined use of cetylpyridinium chloride and tranexamic acid, bitterness and irritation is reduced, and the feeling of use is also satisfactory, and an oral composition excellent in appearance stability is still available. Not achieved. Therefore, development of an oral composition satisfying all of these is desired.

特開平05−000931号公報Japanese Patent Laid-Open No. 05-000931 特開2004−18431号公報JP, 2004-18431, A 特開平04−139117号公報JP 04-139117A 特許第4044748号公報Japanese Patent No. 4044748

本願発明における課題は、塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性を低減し、さらに、経時での変色を抑制し外観安定性に優れる液体口腔用組成物を提供することである。 An object of the present invention is to provide a composition for liquid oral cavity which reduces bitterness and irritation peculiar to cetylpyridinium chloride and tranexamic acid, and further suppresses discoloration over time and has excellent appearance stability.

かかる事情に鑑み、本願発明者らは鋭意研究の結果、(A)塩化セチルピリジニウムを0.01〜0.1重量%、及び(B)トラネキサム酸を0.01〜0.1重量%含有した液体口腔用組成物に、(C)ラフマの抽出物を0.00005〜0.01重量%含有し、かつ、液体口腔用組成物のpHを5.0〜6.5にすると、塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性が低減され、さらに、経時での変色が抑制されることを見出し、本願発明を完成させた。 In view of such circumstances, as a result of earnest research, the inventors of the present application contained 0.01 to 0.1% by weight of (A) cetylpyridinium chloride and 0.01 to 0.1% by weight of tranexamic acid (B). When the liquid oral composition contains 0.00005 to 0.01% by weight of the extract (C) Rahuma and the pH of the liquid oral composition is 5.0 to 6.5, cetylpyridinium chloride is obtained. Further, they found that the bitterness and irritation peculiar to tranexamic acid are reduced, and further discoloration with time is suppressed, and the present invention was completed.

また、本願発明は、エタノールを含有しないことを特徴とする液体口腔用組成物を提供する。 The present invention also provides a liquid oral composition, which is characterized by not containing ethanol.

また、本願発明は、洗口液であることを特徴とする液体口腔用組成物を提供する。 The present invention also provides a liquid oral composition, which is a mouthwash.

本願発明の液体口腔用組成物は、塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性を低減し、さらに、経時での変色が抑制され外観安定性に優れたものであった。 The liquid composition for oral cavity of the present invention has excellent bitterness and irritation characteristic of cetylpyridinium chloride and tranexamic acid, and further has excellent appearance stability by suppressing discoloration over time.

本願発明に用いる成分(A)塩化セチルピリジニウムは、第四級アンモニウム化合物に含まれるカチオン性殺菌剤であり、口腔用組成物において口腔内細菌を殺菌する目的で広く使用されている物質である。 The component (A) cetylpyridinium chloride used in the present invention is a cationic bactericidal agent contained in a quaternary ammonium compound, and is a substance widely used in the composition for oral cavity for the purpose of sterilizing oral bacteria.

成分(A)の含有量は、液体口腔用組成物全体に対して0.01〜0.1重量%であり、好ましくは0.03〜0.08重量%である。0.01重量%より少ないと、口腔内における殺菌効果を十分に発揮できず、また0.1重量%を超えると苦味がさらに増すおそれがある。 The content of the component (A) is 0.01 to 0.1% by weight, preferably 0.03 to 0.08% by weight, based on the entire liquid oral composition. If it is less than 0.01% by weight, the bactericidal effect in the oral cavity cannot be sufficiently exhibited, and if it exceeds 0.1% by weight, bitterness may be further increased.

本願発明に用いる成分(B)トラネキサム酸は、抗プラスミン剤であり、抗プラスミン、出血予防に有効な成分である。 The component (B) tranexamic acid used in the present invention is an antiplasmin agent, and is an effective component for antiplasmin and bleeding prevention.

成分(B)の含有量は、液体口腔用組成物全体に対して0.01〜0.1重量%であり、好ましくは0.03〜0.1重量%である。0.01重量%より少ないと、十分な抗炎症効果が得られず、また0.1重量%を超えると使用感が悪くなり、経時での変色が強くなるおそれがある。 The content of the component (B) is 0.01 to 0.1% by weight, preferably 0.03 to 0.1% by weight, based on the entire liquid oral composition. If it is less than 0.01% by weight, a sufficient anti-inflammatory effect may not be obtained, and if it exceeds 0.1% by weight, the feeling of use may deteriorate and the discoloration with time may become strong.

本願発明に用いる成分(C)は、ラフマの抽出物である。ラフマ(Apocynum Venetum L.)は、キョウチクトウ科バシクルモン属に属し、主に中国の北西部に自生する多年生の草木である。成分(C)は、葉、茎、根等の何れの部位も使用でき、粉砕物、細切物、及びこれらの乾燥物のいずれであってもよい。 Component (C) used in the present invention is an extract of Rahuma. Rafuma (Apocynum Venetum L.) is a perennial plant that belongs to the genus Bascurcumon of the oleander family and mainly grows in northwestern China. The component (C) can be used in any part such as leaves, stems, roots, and may be a crushed product, shredded product, or a dried product thereof.

なお、上記植物抽出物は、抽出溶媒を用いた常法によって取得することができる。抽出する溶媒としては、例えば、水、低級アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール類(1,3−ブチレングリコール、プロピレングリコール、グリセリン等)、ケトン類(アセトン、メチルエチルケトン等)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチル等)、炭化水素類(ヘキサン、ヘプタン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)が挙げられる。これらの溶媒は、1種又は2種以上を混合して用いても良い。好ましくは、水、低級アルコール等の極性溶媒が良く、特に好ましくは、水である。 The above plant extract can be obtained by a conventional method using an extraction solvent. Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene). Glycol, glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether, etc.) Is mentioned. These solvents may be used alone or in combination of two or more. A polar solvent such as water or a lower alcohol is preferable, and water is particularly preferable.

抽出物は、抽出した溶液のまま用いても良く、必要に応じて、濃縮、希釈、濾過、活性炭等による脱色、脱臭、エタノール沈殿等の処理をして用いても良い。さらには、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いても良い。 The extract may be used as it is as an extracted solution, and if necessary, it may be subjected to treatments such as concentration, dilution, filtration, decolorization with activated carbon, deodorization, ethanol precipitation and the like. Furthermore, the extracted solution may be concentrated to dryness, spray-dried, freeze-dried and the like and used as a dried product.

上記成分(C)の含有量は、液体口腔用組成物全体に対して0.00005〜0.01重量%であり、好ましくは0.0001〜0.01重量%である。0.00005重量%より少ないと、十分な苦味抑制効果が得られず、また0.01重量%を超えると抽出物由来のエグ味などを生じるおそれがある。 The content of the component (C) is 0.00005 to 0.01% by weight, preferably 0.0001 to 0.01% by weight, based on the entire liquid oral composition. If it is less than 0.00005% by weight, a sufficient bitterness-suppressing effect cannot be obtained, and if it exceeds 0.01% by weight, an astringent taste derived from the extract may be generated.

本願発明の液体口腔用組成物のpHは上記のように5.0〜6.5の範囲であり、好ましくは5.0〜6.3の範囲である。pHが6.5より高いと、経時での変色抑制効果が不十分になり、外観安定性が劣るおそれがある。
なお、上記pHは、組成物を調製直後に堀場製作所製のpHメーター(型番F−51)を用いて測定し、20℃、3分後の値を示した。
また、pHはなりゆきで上記範囲に調製し得るが、必要に応じてpH調製剤を添加しても良い。pH調整剤としては、特に制限はないが、クエン酸、クエン酸ナトリウム、リン酸一水素ナトリウム、リン酸二水素ナトリウム等が挙げられ、これらの1種又は2種以上を使用することができる。
The pH of the liquid oral composition of the present invention is in the range of 5.0 to 6.5, and preferably in the range of 5.0 to 6.3, as described above. If the pH is higher than 6.5, the effect of suppressing discoloration over time becomes insufficient, and the appearance stability may be poor.
The above pH was measured immediately after the composition was prepared using a pH meter (model number F-51) manufactured by Horiba Ltd., and the value after 3 minutes at 20°C was shown.
The pH can be adjusted within the above range depending on the course, but a pH adjusting agent may be added if necessary. The pH adjuster is not particularly limited, and examples thereof include citric acid, sodium citrate, sodium monohydrogen phosphate, sodium dihydrogen phosphate, and the like, and one or more of these can be used.

本願発明の液体口腔用組成物は、エタノールの含有に関して特に制限はないが、好ましくはエタノールを含有しない方がよい。これにより、刺激性をより低減することができる。 The liquid composition for oral cavity of the present invention is not particularly limited as to the content of ethanol, but preferably it does not contain ethanol. This can further reduce irritation.

本願発明の液体口腔用組成物は、含有成分が可溶化した液体製剤として調製されるもので、例えば原液のまま使用するタイプの洗口液、口中清涼剤、濃縮タイプで使用時に希釈して用いる洗口液、液体歯磨剤等に調製できる。その中でも特に好ましいのは洗口液である。なお、特に洗口液では、歯磨剤のようなペースト状の製剤よりも苦味、刺激等が強く発現するが、本願発明では、このような液体製剤において苦味、刺激を低減し良好な使用感を付与することができる。 The liquid oral composition of the present invention is prepared as a liquid preparation in which the contained components are solubilized, and for example, it is used as a raw mouthwash, a mouthwash, a mouthwash, or a concentrated type, which is diluted when used. It can be prepared as a mouthwash, liquid dentifrice, etc. Of these, the mouth rinse is particularly preferable. In addition, especially in mouthwash, bitterness, irritation, etc. are more strongly expressed than paste-like preparations such as dentifrice, but in the present invention, bitterness, irritation is reduced in such liquid preparation, and a good feeling of use is obtained. Can be granted.

本願発明の液体口腔用組成物には、目的の効果が損なわれない範囲で上記成分以外に、通常の口腔用組成物に用いられる任意の成分を含有することができる。例えば、湿潤剤、界面活性剤、溶剤、甘味剤、着色剤、香料、防腐剤、増粘剤、有効成分等が挙げられる。ただし、これら例示に限定されるものでない。 The liquid composition for oral cavity of the present invention may contain any component used in a usual composition for oral cavity, in addition to the above-mentioned components, within the range where the intended effect is not impaired. For example, wetting agents, surfactants, solvents, sweeteners, coloring agents, flavors, preservatives, thickeners, active ingredients and the like can be mentioned. However, it is not limited to these examples.

次に、実施例を挙げて、本願発明をより詳細に説明する。ただし、本願発明はこれらにより限定されるものではない。なお、含有量は重量%である。 Next, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these. The content is% by weight.

以下に、ラフマを用いた溶媒抽出物の製造例を示す。 Below, the example of manufacture of the solvent extract using Rahuma is shown.

製造例1 ラフマの熱水抽出物
ラフマの葉の乾燥物150gに精製水10Lを加え、95〜100℃で2時間抽出した。ろ液を減圧下で濃縮し、凍結乾燥することでラフマの熱水抽出物を11.5g得た。
Production Example 1 Hot water extract of Rahuma Purified water (10 L) was added to 150 g of dried Rahuma leaf, and extraction was performed at 95 to 100° C. for 2 hours. The filtrate was concentrated under reduced pressure and freeze-dried to obtain 11.5 g of a hot water extract of Rahuma.

製造例2 ラフマの50%エタノール抽出物
ラフマの葉の乾燥物100gに50(v/v)%エタノール水溶液3Lを加え、常温で5日間抽出した。ろ液を減圧下で濃縮乾固して、ラフマの50%エタノール抽出物を5.5g得た。
Production Example 2 50% ethanol extract of Rahuma To 100 g of dried Rahuma leaf was added 3 L of a 50 (v/v)% ethanol aqueous solution, and the mixture was extracted at room temperature for 5 days. The filtrate was concentrated to dryness under reduced pressure to obtain 5.5 g of 50% ethanol extract of Rahuma.

表1〜3に示した組成に従い、実施例1〜13及び比較例1〜6の各液体口腔用組成物(洗口液)を常法により調製し、得られた液体口腔用組成物について下記方法に従って評価した。 According to the compositions shown in Tables 1 to 3, the liquid oral compositions (mouthwashes) of Examples 1 to 13 and Comparative Examples 1 to 6 were prepared by a conventional method, and the obtained liquid oral compositions were as follows. Evaluation was performed according to the method.

(評価方法)
専門パネラー10名が表に示したサンプルの液体口腔用組成物を約10mL口に含み、30秒間すすいだ後、洗口時及び洗口後の(1)苦味、(2)刺激について以下の基準に従って評価した。
(Evaluation method)
Approximately 10 mL of the liquid oral composition of the sample shown in the table by 10 specialist panelists was rinsed for 30 seconds, and after rinsing for 30 seconds, (1) bitterness and (2) irritation, the following criteria Was evaluated according to.

(1)苦味
(評価基準)
4点:苦味をまったく感じない
3点:苦味をほとんど感じない
2点:苦味を感じる
1点:苦味を強く感じる
(判定基準)
◎:平均点が3.5点以上4.0点以下
○:平均点が3.0点以上3.5点未満
△:平均点が2.0点以上3.0点未満
×:平均点が2.0点未満
(1) Bitterness (evaluation standard)
4 points: No bitterness is felt 3 points: Little bitterness is felt 2 points: Bitterness is felt 1 point: Bitterness is strongly felt (criteria)
⊚: Average point is 3.5 points or more and 4.0 points or less ○: Average point is 3.0 points or more and less than 3.5 points Δ: Average point is 2.0 points or more and less than 3.0 points x: Average point is Less than 2.0 points

(2)刺激
(評価基準)
4点:刺激をまったく感じない
3点:刺激をほとんど感じない
2点:刺激を感じる
1点:刺激を強く感じる
(判定基準)
◎:平均点が3.5点以上4.0点以下
○:平均点が3.0点以上3.5点未満
△:平均点が2.0点以上3.0点未満
×:平均点が2.0点未満
(2) Stimulation (evaluation criteria)
4 points: No irritation at all 3 points: Almost no irritation 2 points: irritation is felt 1 point: irritation is strongly felt (criteria)
⊚: Average point is 3.5 points or more and 4.0 points or less ○: Average point is 3.0 points or more and less than 3.5 points Δ: Average point is 2.0 points or more and less than 3.0 points x: Average point is Less than 2.0 points

(3)外観安定性(変色のなさ)
表に示した各サンプルを40℃の恒温槽で3カ月間保存した後に外観安定性(変色)を目視にて観察し、以下の基準に従って評価した。評価は無色透明な水を基準とした。
(判定基準)
◎:変色がまったくなく、無色透明である
○:わずかに淡黄色の変色が見られるが、問題ないレベルである
×:明らかに黄変色が見られる
(3) Appearance stability (no discoloration)
Each sample shown in the table was stored in a constant temperature bath at 40° C. for 3 months, and then the appearance stability (discoloration) was visually observed and evaluated according to the following criteria. The evaluation was based on colorless and transparent water.
(Criteria)
⊚: No discoloration at all, colorless and transparent ○: Slightly pale yellow discoloration is seen, but there is no problem ×: Clearly yellow discoloration is seen

使用原料の詳細は下記の通りである。
・塩化セチルピリジニウム(富士フィルム和光純薬社製)
・トラネキサム酸(協和ファーマケミカル社製)
The details of the raw materials used are as follows.
・Cetylpyridinium chloride (manufactured by Fuji Film Wako Pure Chemical Industries)
・Tranexamic acid (Kyowa Pharma Chemical Co., Ltd.)

上記表1及び2において、実施例1〜13の本願発明の液体口腔用組成物を使用した場合、塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性が低減し、さらに、経時での変色が抑制され外観安定性に優れていた。 In Tables 1 and 2 above, when the liquid oral compositions of the present invention of Examples 1 to 13 are used, the bitterness and irritancy peculiar to cetylpyridinium chloride and tranexamic acid are reduced, and further, discoloration over time is caused. It was suppressed and had excellent appearance stability.

上記表3において、成分(A)の含有量が0.1重量%より多い場合(比較例1)、あるいは成分(B)の含有量が0.1重量%より多い場合(比較例2)、あるいは成分(C)の含有量が0.00005重量%より少ない場合(比較例3)、苦味及び刺激を抑制することができなかった。また、成分(C)の含有量が0.01重量%より多い場合(比較例4)、植物由来のエグ味が出て、苦味を抑制することができなかった。さらに、液体口腔用組成物のpHが6.5より大きい場合(比較例5及び6)、トラネキサム酸の経時での変色が起こり、外観安定性が悪くなった。 In Table 3 above, when the content of the component (A) is more than 0.1% by weight (Comparative Example 1) or when the content of the component (B) is more than 0.1% by weight (Comparative Example 2), Alternatively, when the content of the component (C) was less than 0.00005% by weight (Comparative Example 3), bitterness and irritation could not be suppressed. Moreover, when the content of the component (C) was more than 0.01% by weight (Comparative Example 4), an astringent taste derived from a plant appeared and the bitterness could not be suppressed. Furthermore, when the pH of the liquid oral composition was higher than 6.5 (Comparative Examples 5 and 6), discoloration of tranexamic acid occurred over time, and the appearance stability was deteriorated.

(実施例14)
(成分) (重量%)
1.塩化セチルピリジニウム 0.04
2.トラネキサム酸 0.03
3.ラフマの50%エタノール抽出物(製造例2) 0.004
4.グリセリン 4.0
5.プロピレングリコール 4.0
6.ポリオキシエチレン硬化ヒマシ油 0.4
7.キシリトール 3.0
8.クエン酸 0.03
9.クエン酸ナトリウム 0.27
10.香料 0.1
11.メチルパラベン 0.1
12.精製水 残余
(調製方法)
実施例1〜13と同様の方法で調製した。
pH=6.2
(Example 14)
(Component) (% by weight)
1. Cetylpyridinium chloride 0.04
2. Tranexamic acid 0.03
3. Rafuma 50% ethanol extract (Production Example 2) 0.004
4. Glycerin 4.0
5. Propylene glycol 4.0
6. Polyoxyethylene hydrogenated castor oil 0.4
7. Xylitol 3.0
8. Citric acid 0.03
9. Sodium citrate 0.27
10. Perfume 0.1
11. Methylparaben 0.1
12. Purified water Residual (preparation method)
Prepared in the same manner as in Examples 1-13.
pH=6.2

(実施例15)
(成分) (重量%)
1.塩化セチルピリジニウム 0.06
2.トラネキサム酸 0.04
3.ラフマの50%エタノール抽出物(製造例2) 0.007
4.グリセリン 7.0
5.プロピレングリコール 4.0
6.ポリオキシエチレン硬化ヒマシ油 0.5
7.ソルビトール 5.0
8.リン酸一水素ナトリウム 0.05
9.リン酸二水素ナトリウム 0.25
10.香料 0.15
11.メチルパラベン 0.1
12.精製水 残余
(調製方法)
実施例1〜13と同様の方法で調製した。
pH=5.9
(Example 15)
(Component) (% by weight)
1. Cetylpyridinium chloride 0.06
2. Tranexamic acid 0.04
3. Rafuma 50% ethanol extract (Production Example 2) 0.007
4. Glycerin 7.0
5. Propylene glycol 4.0
6. Polyoxyethylene hydrogenated castor oil 0.5
7. Sorbitol 5.0
8. Sodium monohydrogen phosphate 0.05
9. Sodium dihydrogen phosphate 0.25
10. Perfume 0.15
11. Methylparaben 0.1
12. Purified water Residual (preparation method)
Prepared in the same manner as in Examples 1-13.
pH=5.9

実施例14及び15に示す液体口腔用組成物を評価したところ、塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性が低減し、さらに、経時での変色が抑制され外観安定性に優れていた。 When the liquid oral compositions shown in Examples 14 and 15 were evaluated, the bitterness and irritancy peculiar to cetylpyridinium chloride and tranexamic acid were reduced, and further, discoloration over time was suppressed and the appearance stability was excellent. ..

本願発明によれば、塩化セチルピリジニウム及びトラネキサム酸に特有の苦味及び刺激性を低減し、さらに、経時での変色が抑制され外観安定性に優れる液体口腔用組成物を提供できる。 ADVANTAGE OF THE INVENTION According to this invention, the bitterness and irritation peculiar to cetylpyridinium chloride and tranexamic acid are reduced, the discoloration over time is suppressed, and the liquid oral composition excellent in appearance stability can be provided.

Claims (3)

次の成分(A)〜(C);
(A)塩化セチルピリジニウム 0.01〜0.1重量%
(B)トラネキサム酸 0.01〜0.1重量%
(C)ラフマの抽出物 0.00005〜0.01重量%
を含有し、かつpHが5.0〜6.5であることを特徴とする液体口腔用組成物。
The following components (A) to (C);
(A) Cetylpyridinium chloride 0.01 to 0.1% by weight
(B) Tranexamic acid 0.01 to 0.1% by weight
(C) Rafuma extract 0.00005-0.01% by weight
And a pH of 5.0 to 6.5.
エタノールを含有しないことを特徴とする請求項1記載の液体口腔用組成物。 The liquid oral composition according to claim 1, which does not contain ethanol. 洗口液である請求項1又は2記載の液体口腔用組成物。 The liquid oral composition according to claim 1 or 2, which is a mouthwash.
JP2018232680A 2018-12-12 2018-12-12 Liquid oral composition Active JP7108304B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018232680A JP7108304B2 (en) 2018-12-12 2018-12-12 Liquid oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018232680A JP7108304B2 (en) 2018-12-12 2018-12-12 Liquid oral composition

Publications (2)

Publication Number Publication Date
JP2020093998A true JP2020093998A (en) 2020-06-18
JP7108304B2 JP7108304B2 (en) 2022-07-28

Family

ID=71084545

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018232680A Active JP7108304B2 (en) 2018-12-12 2018-12-12 Liquid oral composition

Country Status (1)

Country Link
JP (1) JP7108304B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101659324B1 (en) * 2014-07-18 2016-09-23 충남대학교산학협력단 Rumen canulla for ruminant animals

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017222579A (en) * 2016-06-13 2017-12-21 日本メナード化粧品株式会社 Oral composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017222579A (en) * 2016-06-13 2017-12-21 日本メナード化粧品株式会社 Oral composition

Also Published As

Publication number Publication date
JP7108304B2 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
US6169118B1 (en) Flavor blend for masking unpleasant taste of zinc compounds
JP7251998B2 (en) Liquid oral composition
KR101821422B1 (en) Dentifrice composition
JP5613990B2 (en) Tooth dentinal tubule sealant and oral composition
WO2011055708A1 (en) Isopropyl methyl phenol-containing liquid composition for oral cavity
KR101624764B1 (en) Dentifrice composition
WO2016006647A1 (en) Composition for use in oral cavity
JP5721973B2 (en) Oral composition
JP2020011951A (en) Oral composition
JP7108304B2 (en) Liquid oral composition
JP6441669B2 (en) Liquid oral composition
JP3706614B2 (en) Oral composition for suppressing bad breath
KR101703269B1 (en) Oral care composition comprising Magnolia officinalis extract and bicarbonate
JP3987593B2 (en) Oral composition containing sodium chloride and magnesium chloride
JP2023533273A (en) Oral composition for improving bad breath
KR101195528B1 (en) Oral composition comprising zingiber officinales extract
JP2010037290A (en) Dentifrice
KR101287800B1 (en) Oral composition
JP5892716B2 (en) Oral composition
KR101344803B1 (en) Oral care composition comprising extract of machilus thunbergii and sequestering agent
KR102597684B1 (en) Oral composition comprising amaranth extract
JP2022080125A (en) Liquid oral composition
JP2011073970A (en) Composition for oral cavity or throat
KR101195527B1 (en) Method for manufacturing zingiber officinales extract, oral composition comprising zingiber officinales extract by manufactured thereof and ing
KR20180048041A (en) Oral Cleaning Composition and Oral Products Using Thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211029

TRDD Decision of grant or rejection written
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220622

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220628

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220708

R150 Certificate of patent or registration of utility model

Ref document number: 7108304

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150